K. Altundag Et Al. , "Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , vol.31, Illinois, United States Of America, 2013
Altundag, K. Et Al. 2013. Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.. 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Altundag, K., Aksoy, S., Sendur, M. A. N., Guler, E. N., Gullu, I. H., & Ozisik, Y. Y., (2013). Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine. . 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Altundag, Kadri Et Al. "Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2013
Altundag, Kadri Et Al. "Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013
Altundag, K. Et Al. (2013) . "Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Kadri Altundag Et Al. }, title={Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.}, congress name={49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2013}}